UK markets open in 3 hours 57 minutes

WuXi Biologics (Cayman) Inc. (2269.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
78.600+1.400 (+1.81%)
As of 10:48AM HKT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
10,290,050
10,290,050
5,612,384
3,983,687
2,534,453
Cost of revenue
5,461,153
5,461,153
3,079,418
2,324,858
1,516,698
Gross profit
4,828,897
4,828,897
2,532,966
1,658,829
1,017,755
Operating expenses
Research development
501,583
501,583
303,734
259,651
169,287
Selling general and administrative
1,000,579
1,000,579
605,851
444,368
270,151
Total operating expenses
1,364,232
1,364,232
771,431
601,770
323,615
Operating income or loss
3,464,665
3,464,665
1,761,535
1,057,059
694,140
Interest expense
39,191
39,191
42,732
19,605
0
Income before tax
3,993,119
3,993,119
1,965,760
1,126,633
737,722
Income tax expense
484,538
484,538
273,066
116,296
107,257
Income from continuing operations
3,508,581
3,508,581
1,692,694
1,010,337
630,465
Net income
3,388,478
3,388,478
1,688,886
1,013,805
630,592
Net income available to common shareholders
3,388,478
3,388,478
1,688,886
1,013,805
630,592
Basic EPS
-
-
0.43
0.27
0.17
Diluted EPS
-
-
0.40
0.25
0.16
Basic average shares
-
4,173,681
3,952,964
3,717,120
3,631,620
Diluted average shares
-
-
4,209,169
3,997,125
3,941,614
EBITDA
-
4,514,093
2,311,501
1,367,603
881,492